AAAAAA

   
Results: 1-10 |
Results: 10
Ipriflavone and osteoporosis - Reply
Authors: Alexandersen, P Riis, B
Citation: P. Alexandersen et B. Riis, Ipriflavone and osteoporosis - Reply, J AM MED A, 286(15), 2001, pp. 1836-1837
Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial
Authors: Alexandersen, P Toussaint, A Christiansen, C Devogelaer, JP Roux, C Fechtenbaum, J Gennari, C Reginster, JY
Citation: P. Alexandersen et al., Ipriflavone in the treatment of postmenopausal osteoporosis - A randomizedcontrolled trial, J AM MED A, 285(11), 2001, pp. 1482-1488
Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy
Authors: Alexandersen, P Riis, BJ Stakkestad, JA Delmas, PD Christiansen, C
Citation: P. Alexandersen et al., Efficacy of levormeloxifene in the prevention of postmenopausal bone loss and on the lipid profile compared to low dose hormone replacement therapy, J CLIN END, 86(2), 2001, pp. 755-760
Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits
Authors: Bjarnason, NH Haarbo, J Byrjalsen, I Alexandersen, P Kauffman, RF Christiansen, C
Citation: Nh. Bjarnason et al., Raloxifene and estrogen reduces progression of advanced atherosclerosis - a study in ovariectomized, cholesterol-fed rabbits, ATHEROSCLER, 154(1), 2001, pp. 97-102
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
Authors: Christgau, S Bitsch-Jensen, O Bjarnason, NH Henriksen, EG Qvist, P Alexandersen, P Henriksen, DB
Citation: S. Christgau et al., Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy, BONE, 26(5), 2000, pp. 505-511
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium
Authors: Byrjalsen, I Alexandersen, P Christiansen, C
Citation: I. Byrjalsen et al., Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium, BR J OBST G, 107(3), 2000, pp. 347-355
Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects
Authors: Alexandersen, P Byrjalsen, I Christiansen, C
Citation: P. Alexandersen et al., Piperazine oestrone sulphate and interrupted norethisterone in postmenopausal women: effects on bone mass, lipoprotein metabolism, climacteric symptoms, and adverse effects, BR J OBST G, 107(3), 2000, pp. 356-364
Bone densitometry: A new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment
Authors: Ravn, P Alexandersen, P Mollgaard, A
Citation: P. Ravn et al., Bone densitometry: A new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment, OSTEOPOR IN, 9(4), 1999, pp. 277-283
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorptionin postmenopausal women: A randomized study
Authors: Alexandersen, P Riis, BJ Christiansen, C
Citation: P. Alexandersen et al., Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorptionin postmenopausal women: A randomized study, J CLIN END, 84(9), 1999, pp. 3013-3020
Natural androgens inhibit male atherosclerosis - A study in castrated, cholesterol-fed rabbits
Authors: Alexandersen, P Haarbo, J Byrjalsen, I Lawaetz, H Christiansen, C
Citation: P. Alexandersen et al., Natural androgens inhibit male atherosclerosis - A study in castrated, cholesterol-fed rabbits, CIRCUL RES, 84(7), 1999, pp. 813-819
Risultati: 1-10 |